Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer

This study is currently recruiting participants.
Verified June 2013 by Hospital General Universitario Gregorio Marañon
Sponsor:
Collaborators:
UNC Lineberger Comprehensive Cancer Center
Hospital Universitario Ramon y Cajal
Hospital San Carlos, Madrid
Centro Nacional de Investigaciones Oncologicas CARLOS III
Information provided by (Responsible Party):
Miguel Martín Jiménez, Hospital General Universitario Gregorio Marañon
ClinicalTrials.gov Identifier:
NCT01560663
First received: March 20, 2012
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)